Serial changes in high-sensitive troponin i predict outcome in patients with decompensated heart failure

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 37-42

  Xue, Yang ^a   Clopton, Paul ^b   Peacock, William F ^c   Maisel, Alan S ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

brain natriuretic peptide; Decompensated heart failure; Mortality; Serial measurement; Troponin I

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CALIFORNIA; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME; TROPONIN I;

EID: 78650400736     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq210     Document Type: Article

References (20)

1. Löwbeer C Gustafsson SA Seeberger A Bouvier F Hulting J. Serum cardiac tro-ponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest 2004;64:667-676.
2. Goto T Takase H Toriyama T Sugiura T Sato K Ueda R Dohi Y. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003;89:1303-1307.
3. Horwich TB Patel J MacLellan WR Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics progressive left ventricular dysfunction and increased mortality rates in advanced heart failure. Circulation 2003;108:833-838.
4. Fonarow GC Horwich TB. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 2003;4(Suppl 4): S20-S28.
5. Peacock WF IV De Marco T Fonarow GC Diercks D Wynne J Apple FS Wu AH; ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-2126.
6. Alpert JS Thygesen K Antman E Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
7. Emdin M Vittorini S Passino C Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009;11:331-335.
8. Boisot S Beede J Isakson S Chiu A Clopton P Januzzi J Maisel AS Fitzgerald RL. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail 2008;14:732-738.
9. Waldo SW Beede J Isakson S Villard-Saussine S Fareh J Clopton P Fitzgerald RL Maisel AS. Pro-B-type natriuretic peptide levels in acute decompen-sated heart failure. J Am Coll Cardiol 2008;51:1874-1882.
10. Biosite. Triage BNP [package insert]. San Diego CA: Biosite; 2002.
11. Sykes E Karcher RE Eisenstadt J Tushman DA Balasubramaniam M Gusway J Perason VJ. Analytical relationships among Biosite Bayer and Roche methods for BNP and NT-proBNP. Am J Clin Pathol 2005;123:584-590.
12. Stanton EB Hansen MS Sole MJ Gawad Y Packer M Pitt B Swedberg K Rouleau JL; PROFILE investigators. Cardiac troponin I a possible predictor of survival in patients with stable congestive heart failure. Can J Cardiol 2005;21:39-43.
13. Haider KH Stimson WH. Cardiac troponin-I: a biochemical marker for cardiac cell necrosis. Dis Markers 1993;11:205-215.
14. Liang F Wu J Garami M Gardner DG. Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J Biol Chem 1997;272: 28050-28056.
15. Ishii J Nomura M Nakamura Y Naruse H Mori Y Ishikawa T Ando T Kurokawa H Kondo T Nagamura Y Ezaki K Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002;89:691-695.
16. Ishii J Cui W Kitagawa F Kuno T Nakamura Y Naruse H Mori Y Ishikawa T Nagamura Y Kondo T Oshima H Nomura M Ezaki K Hishida H. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 2003;49: 2020-2026.
17. Taniguchi R Sato Y Nishio Y Kimura T Kita T. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 2006;21:344-349.
18. Daniels LB Laughlin GA Clopton P Maisel AS Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008;52:450-459.
19. Fonarow GC Peacock WF Horwich TB Phillips CO Givertz MM Lopatin M Wynne J; ADHERE Scientific Advisory Committee and Investigators. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 2008;101:231-237.
20. Ilva T Lassus J Siirilä-Waris K Melin J Peuhkurinen K Pulkki K Nieminen MS Mustonen H Porela P Harjola VP. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008;10:772-779.